Careventures
Careventures
  • Home
  • About us
  • Companies
  • Team
  • News

475 Avenue Louise
1050 Brussels (Belgium)
+32 (0) 22 457 105

Rbla. Catalunya 60 Pral. 2ª
08007 Barcelona (Spain)
+34 932 721 320

Linkedin

info@careventures.eu

January 2023

Corus expands into the UK with the integration of Byrnes Dental Laboratory

Read more
November 2022

Corus grows in Spain with the acquisition of two laboratories in Seville and Madrid

Read more
October 2022

Centogene reaches 12,500 patient milestone in world’s largest observational study on Parkinson’s disease genetics

Read more
August 2022

Corus expands into Scandinavia with the integration of Nordentic, the region’s largest player in dental technology

Read more
June 2022

Centogene and Agios expand partnership for clinical development of PYRUKYND® (mitapivat) to treat children with rare blood disease

Read more
April 2022

Centogene and Takeda extend market access and expansion partnership to advance patient care globally

Read more
April 2022

Sophie Wilford, Qovetia’s Director of Marketing and Communication, launched a webinar addressed to veterinarians

Read more
March 2022

Centogene announces expansion of data access and collaboration agreement with Pfizer

Read more
March 2022

Corus and Signadens join forces to create the European leader of digital dental prosthesis

Read more
Careventures

Careventures is an independent pan-European private equity firm exclusively dedicated to healthcare.

Contact

475 Avenue Louise
1050 Brussels (Belgium) 
+32 (0) 22 457 105

Rbla. Catalunya 60 Pral. 2ª
08007 Barcelona (Spain) 
+34 932 721 320

info@careventures.eu

Follow us

  • Linkedin

Legal

  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy

©2023 Careventures. All rights reserved.

This website uses cookies to ensure you get the best experience on our website. Learn more